Skip to main content
Figure 4 | BMC Immunology

Figure 4

From: Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation

Figure 4

Beta-escin reduces cytokine production in an OVA-induced model of allergic airway inflammation. BAL fluid was collected 15 h after the last OVA-challenge from sensitized BALB/c mice of the 4 different treatment groups as described in Fig. 3. (A) IL-5 and (B) IL-13 levels in the BALF of individual mice from each group were determined by ELISA. Each bar represents the mean of 11 - 16 mice from 3 independent, but identical experiments ± SEM out of a series of similar experiments. Significant differences of the dex and escin groups to the PBS group are indicated with: * p < 0.05 and ** p < 0.01.

Back to article page